Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07659223

Improving Outcomes for Juvenile Idiopathic Arthritis

Conditions: Juvenile Idiopahtic Arthritis

Sex: All
Ages: 0 Years – 16 Years
Healthy volunteers: No
Phase: NA
Enrollment: 116
Sponsor: Region Stockholm

Location: Karolinska University Hospital Stockholm

Summary

Children and parents often experience uncertainty and stress when juvenile idiopathic arthritis (JIA) is first diagnosed, which creates a need for structured support. Juvenile Idiopathic Support Program (JASP-1) provide patient-and family centered support during the first year after diagnosis. However, little is known about how a support program like JASP-1 can influence outcomes. Therefore, this study aimed to longitudinally examine registry data from children who participated in JASP 1 and to compare the outcomes with registry data from a matched control group.

Eligibility Criteria

Inclusion Criteria: * For the JASP-1: Diagnosed with JIA and have completed the JASP-1. * For the control group: Diagnosed with JIA at the same clinic as above Exclusion Criteria: * No JIA diagnosis * Change of diagnose during the year * Do not understand or speak Swedish

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07659223). StuddyBuddy aggregates publicly available trial information.